The
current NIH-funded trial aims to enroll about 16 spina bifida patients;
the original design was not blind and had no control group. Peters
says NIH has “created an oversight committee for our study. We met
with them a few weeks ago and are addressing their comments. We will
be submitting a revised protocol soon for their review.”